Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Evaluation of A2a Receptor Binding Affinity from US Patent US20240217978: "COMPOUND AS ADENOSINE A2a RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME"
Assay data:395 Active, 50 Activity ≤ 1 nM, 388 Activity ≤ 1 µM, 396 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Adenosine Receptor Activity Assay from US Patent US11974991: "Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylates"
Assay data:11 Active, 5 Activity ≤ 1 µM, 13 Tested
Adenosine Receptor Time-Resolved Fluorescence Resonance Energy Transfer (TRFRET) Binding Assay from US Patent US20240083904: "ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR"
Assay data:13 Active, 10 Activity ≤ 1 nM, 13 Activity ≤ 1 µM, 13 Tested
Measurement of A2A or A2B Binding Affinity Using Radioligand Binding from US Patent US20240076297: "ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY"
Assay data:28 Active, 3 Activity ≤ 1 nM, 28 Activity ≤ 1 µM, 28 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Measurement of A2A or A2B Binding Affinity Using SPA from US Patent US20240076297: "ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY"
Assay data:18 Active, 15 Activity ≤ 1 µM, 18 Tested
Determination of the Effect of a SERCA Agonist on the Reduction of ER Stress from US Patent US11890279: "Quinolines that modulate SERCA and their use for treating disease"
Assay data:11 Tested
SummaryRelated BioAssays by DepositorRelated BioAssays by Target
Cross screening panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Safety47 Scan (DiscoverX - Eurofins)
Adenosine A2A Eurofins Panlabs panel
A2A/H Eurofins SafetyScreen44 (BI)
Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay
Assay data:16 Active, 3 Activity ≤ 1 µM, 1202 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on